AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | 0.0% | 785 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | +20.0% | 785 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 785 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 785 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -25.0% | 785 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | – | 785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,691,151 | $11,990,000 | 3.83% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $1,983,000 | 2.06% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $19,143,000 | 1.78% |
| Samsara BioCapital, LLC | 883,720 | $6,266,000 | 1.75% |
| Nantahala Capital Management | 3,123,430 | $22,145,000 | 0.68% |
| Opaleye Management Inc. | 375,000 | $2,659,000 | 0.52% |
| Lion Point Capital, LP | 300,000 | $2,127,000 | 0.47% |
| Abingworth LLP | 240,500 | $1,703,000 | 0.36% |
| Orbimed Advisors | 4,015,524 | $28,470,000 | 0.36% |
| Sio Capital Management, LLC | 211,104 | $1,497,000 | 0.30% |